Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Birch pollen immunotherapy for hazelnut allergy
NL-OMON26371Active, not recruiting
- Sponsor
- ALK-Abelló
- Start
- Apr 2004
- Countries
- 1
01
Overview
Double-blind, single-arm trial of birch pollen extract in Hazelnut allergy and birch pollen allergy, sponsored by ALK-Abelló. Started Apr 2004; status: active, not recruiting.
02
Drugs
birch pollen extract
03
Conditions
Hazelnut allergybirch pollen allergy
Beyond the preview
Go deeper on NL-OMON26371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26371.